Zoledronic acid: a guide to its use in Paget's disease of bone

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.10, 2007-10, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zoledronic Acid: A Review of its Use in the Treatment of Paget's Disease of Bone

By Keating Gillian M. Scott Lesley J.

Drugs, Vol. 67, Iss. 5, 2007-01 ,pp. : 793-804

Adis International

Access to resources Recommend Favorite

Zoledronic acid for treatment of Paget's disease of bone

By Devogelaer Jean-Pierre Manicourt Daniel H

Expert Opinion on Pharmacotherapy, Vol. 8, Iss. 16, 2007-11 ,pp. : 2863-2869

Informa Healthcare

Access to resources Recommend Favorite

Zoledronic acid dominant option for Paget's disease

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Review of its Use in the Management of Bone Metastases of Malignancy

By Dhillon Sohita Lyseng-Williamson Katherine A.

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 507-534

Adis International

Access to resources Recommend Favorite

Zoledronic Acid: A Pharmacoeconomic Review of its Use in the Management of Bone Metastases

By McKeage Kate Plosker Greg L.

PharmacoEconomics, Vol. 26, Iss. 3, 2008-01 ,pp. : 251-268

Adis International

Access to resources Recommend Favorite